| Abbreviations | Meaning |
 | PN1BII | Tumor Metastases To 4 Or More Lymph Nodes [0.2 To 2.0 Cm] |
 | STS | Soft Tissue Sarcoma |
 | LIFR | Leukemia Inhibitory Factor Receptor |
 | KS | Kaposi Sarcoma |
 | T1 | Breast Tumor Smaller Than 2 Cm [TNM (tumor-node-metastasis) Classification]; Longitudinal Relaxation Time |
 | NBS | Neuroblastoma Supressor |
 | CCPT | Chinese Cancer Prevention Trial |
 | CASA | Cancer-associated Serum Antigen |
 | BCEI | Breast Cancer Estrogen-inducible |
 | T-CLL | T-cell Chronic Lymphatic Leukemia |
 | TCCA, TCCAV | Transitional Cell Cancer-associated [virus] |
 | MLVAR | Amphotropic Receptor For Murine Leukemia Virus |
 | NCI | National Cancer Institute (USA) |
 | CCPMS | Cancer Centre Patient Management System [Australia]; Computer-assisted Clinical Pathway Management System |
 | MCSPG | Melanoma-specific Chondroitin Sulfate Proteoglycan |